CPT2 and chronic kidney disease: CPT2, a lipid transporter in the heart and kidney, significantly increased during CKD modeling, indicating a promotion in fatty acid transport, while proteins related to fatty acid β oxidation, such as ACAA2 and ACADM (Supplementary Figure S1f), showed a decrease.